Proteomic Analysis of the Systemic Response to Radiographic Contrast Media

Clinical Proteomics

Juan Martinez¹  Charlotte Mobarak²  Warren K. Laskey¹  Cheri Wells¹  Mark Ricciardi¹  Sarah Rohde²  Armin Foghi¹ 

[1] Department of Medicine—Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, USADepartment of Medicine—Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, USADepartment of Medicine—Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, USA;Biomedical Sciences—Neurosciences Department, University of New Mexico Health Sciences Center, Albuquerque, USABiomedical Sciences—Neurosciences Department, University of New Mexico Health Sciences Center, Albuquerque, USABiomedical Sciences—Neurosciences Department, University of New Mexico Health Sciences Center, Albuquerque, USA

关键词: Proteomics;    Radiographic contrast media;    Coronary angiography;    iTRAQ labeling;    Mass spectrometry;   

DOI  :  10.1007/s12014-010-9048-x

来源: Humana Press Inc

【 摘 要 】

Abstract

Introduction

Radiographic contrast media (RCM) have numerous effects on the hemostatic system, inflammatory pathways, and vascular endothelium. Given the increasing number of high-risk patients undergoing radiographic procedures, more information regarding the systemic effects of RCM is needed.

Methods

Blood samples prior to baseline, 4 and 24 h following elective coronary angiography in 10 patients, were subjected to matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Data are presented as the ratio of the protein mass at 4 (iTRAQ4) and 24 h (iTRAQ24) compared to baseline. A ratio >1.0 and a ratio <1.0 indicate production and consumption, respectively, relative to baseline.

Results

In this sample, we identified 102 proteins with a confidence interval of ≥90%. Six proteins were identified at each time point in all patients. Of the proteins identified, apolipoprotein A-I, apolipoprotein A-II, complement C3, fibrinogen beta chain, immunoglobulin α, and prothrombin revealed an iTRAQ ratio <1.0 at 4 h when compared to baseline (all with p value <0.05) and a trend toward baseline levels at 24 h.

Conclusions

Systemic administration of RCM results in a variety of alterations to the proteome. Of interest, there is activation of the thrombotic and inflammatory pathways as well as an interaction with lipoprotein metabolism. These changes are most pronounced at 4 h but may persist through 24 h and may be of clinical relevance in patients at risk for thrombotic- and inflammatory-mediated consequences of atherosclerosis.

【 授权许可】

Unknown